Prednisolone
From Pharmacopedia
More actions
Prednisolone (and prednisolone sodium phosphate, acetate, etc.)
Prelone, Pediapred, Orapred ODT, Millipred, Veripred
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Pharmacy
Starting dose
Pediatric 1-2 mg/kg/d (max 60 mg) PO for asthma exacerbation; adult dosing similar to prednisone milligram-for-milligram (~1:1 potency)
Preparations
5 mg tablets; 5 mg/5 mL, 10 mg/5 mL, 15 mg/5 mL oral solutions (sweetened pediatric); 5 mg/5 mL syrup; ophthalmic 0.12%, 1% suspensions and 1% solution
US FDA Max
Indication-specific
Pharmacology
Routes
Oral, ophthalmic, IV (prednisolone sodium phosphate), IM
Onset
Hours
Duration
Biologic 12-36 hours (intermediate-acting)
Half-life
Plasma 2-3 hours; biologic ~18-36 hours[1]
Bioavailability
~70% (oral)[1]
Pregnancy
Use when benefits outweigh; small association with oral clefts debated.[citation needed]
Legal status
Rx-only in US
Purported mechanism
Prednisolone is the active form of prednisone (no hepatic activation required); it binds the glucocorticoid receptor to broadly remodel inflammatory, immune, and metabolic transcription.0 Preferred over prednisone in advanced hepatic dysfunction where hepatic 11β-HSD1 activation is impaired. Liquid formulations are the workhorse pediatric oral corticosteroid for asthma and croup[1].
References
- ↑ 1.0 1.1 1.2 FDA Prescribing Information, Orapred ODT (prednisolone sodium phosphate), Concordia, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021959s016lbl.pdf